Is Core Laboratories Stock a Good Investment?
Core Laboratories Investment Advice | CLB |
- Examine Core Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Core Laboratories' leadership team and their track record. Good management can help Core Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Oil & Gas Equipment & Services space and any emerging trends that could impact Core Laboratories' business and its evolving consumer preferences.
- Compare Core Laboratories' performance and market position to its competitors. Analyze how Core Laboratories is positioned in terms of product offerings, innovation, and market share.
- Check if Core Laboratories pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Core Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Core Laboratories NV stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Core Laboratories NV is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Core Laboratories Stock
Researching Core Laboratories' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 5.34. The company has Price/Earnings To Growth (PEG) ratio of 1.83. Core Laboratories last dividend was issued on the 4th of November 2024. The entity had 2:1 split on the 9th of July 2010.
To determine if Core Laboratories is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Core Laboratories' research are outlined below:
| Core Laboratories had very high historical volatility over the last 90 days | |
| Core Laboratories is unlikely to experience financial distress in the next 2 years | |
| Core Laboratories has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| On 25th of November 2024 Core Laboratories paid $ 0.01 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Why Is Core Laboratories Up 11.5 percent Since Last Earnings Report |
Core Laboratories Quarterly Accounts Payable |
|
Core Laboratories uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Core Laboratories NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Core Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Core Laboratories' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-04-27 | 2022-03-31 | 0.09 | 0.08 | -0.01 | 11 | ||
2003-05-09 | 2003-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2002-05-07 | 2002-03-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2000-07-28 | 2000-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2000-04-28 | 2000-03-31 | 0.06 | 0.05 | -0.01 | 16 | ||
1999-04-30 | 1999-03-31 | 0.01 | 0.02 | 0.01 | 100 | ||
1998-04-23 | 1998-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
1997-08-14 | 1997-06-30 | 0.07 | 0.08 | 0.01 | 14 |
Know Core Laboratories' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Core Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Core Laboratories NV backward and forwards among themselves. Core Laboratories' institutional investor refers to the entity that pools money to purchase Core Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 819.6 K | Btim Corp | 2024-09-30 | 600.8 K | Van Eck Associates Corporation | 2024-06-30 | 539.9 K | Fred Alger Management, Llc | 2024-09-30 | 535.9 K | Charles Schwab Investment Management Inc | 2024-09-30 | 529.5 K | Bank Of New York Mellon Corp | 2024-06-30 | 516.1 K | Northern Trust Corp | 2024-09-30 | 499.6 K | Gendell Jeffrey L | 2024-09-30 | 460.7 K | Wayne Hummer Investments Llc | 2024-06-30 | 382.1 K | Ariel Investments, Llc | 2024-09-30 | 10 M | Blackrock Inc | 2024-06-30 | 7.8 M |
Core Laboratories' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 955.43 M.Market Cap |
|
Core Laboratories' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.15 | |
| Return On Capital Employed | 0.11 | 0.21 | |
| Return On Assets | 0.06 | 0.10 | |
| Return On Equity | 0.16 | 0.32 |
Determining Core Laboratories' profitability involves analyzing its financial statements and using various financial metrics to determine if Core Laboratories is a good buy. For example, gross profit margin measures Core Laboratories' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Core Laboratories' profitability and make more informed investment decisions.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management manipulating its earnings.
Evaluate Core Laboratories' management efficiency
Core Laboratories has Return on Asset of 0.0589 % which means that on every $100 spent on assets, it made $0.0589 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1116 %, implying that it generated $0.1116 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.15. The current year's Return On Capital Employed is expected to grow to 0.21. At present, Core Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.92 | 2.64 | |
| Tangible Book Value Per Share | 2.64 | 2.78 | |
| Enterprise Value Over EBITDA | 14.55 | 12.62 | |
| Price Book Value Ratio | 3.67 | 6.42 | |
| Enterprise Value Multiple | 14.55 | 12.62 | |
| Price Fair Value | 3.67 | 6.42 | |
| Enterprise Value | 4.5 B | 2.7 B |
The decision-making processes within Core Laboratories are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Dividend Yield 0.002 | Forward Dividend Yield 0.002 | Forward Dividend Rate 0.04 | Beta 2.362 |
Basic technical analysis of Core Stock
As of the 30th of November, Core Laboratories shows the Mean Deviation of 2.24, risk adjusted performance of 0.0456, and Downside Deviation of 2.61. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Core Laboratories' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Core Laboratories' Outstanding Corporate Bonds
Core Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Core Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Core bonds can be classified according to their maturity, which is the date when Core Laboratories NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Core Laboratories' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Core Laboratories' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0456 | |||
| Market Risk Adjusted Performance | 0.1096 | |||
| Mean Deviation | 2.24 | |||
| Semi Deviation | 2.46 | |||
| Downside Deviation | 2.61 | |||
| Coefficient Of Variation | 2008.0 | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.41 | |||
| Information Ratio | 0.0049 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0996 | |||
| Maximum Drawdown | 14.81 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 3.99 | |||
| Downside Variance | 6.79 | |||
| Semi Variance | 6.07 | |||
| Expected Short fall | (2.62) | |||
| Skewness | 0.9535 | |||
| Kurtosis | 3.06 |
| Risk Adjusted Performance | 0.0456 | |||
| Market Risk Adjusted Performance | 0.1096 | |||
| Mean Deviation | 2.24 | |||
| Semi Deviation | 2.46 | |||
| Downside Deviation | 2.61 | |||
| Coefficient Of Variation | 2008.0 | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.41 | |||
| Information Ratio | 0.0049 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0996 | |||
| Maximum Drawdown | 14.81 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 3.99 | |||
| Downside Variance | 6.79 | |||
| Semi Variance | 6.07 | |||
| Expected Short fall | (2.62) | |||
| Skewness | 0.9535 | |||
| Kurtosis | 3.06 |
Consider Core Laboratories' intraday indicators
Core Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Core Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Core Laboratories Corporate Filings
| 14th of November 2024 Other Reports | ViewVerify | |
| 13th of November 2024 Other Reports | ViewVerify | |
10Q | 24th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 23rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Core Stock media impact
Far too much social signal, news, headlines, and media speculation about Core Laboratories that are available to investors today. That information is available publicly through Core media outlets and privately through word of mouth or via Core internal channels. However, regardless of the origin, that massive amount of Core data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Core Laboratories news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Core Laboratories relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Core Laboratories' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Core Laboratories alpha.
Core Laboratories Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Core Laboratories can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Core Laboratories Corporate Management
| Gwendolyn MBA | Senior Relations | Profile | |
| J Dumas | Vice President Business Development | Profile | |
| Martha Carnes | Presiding Non-Executive Lead Independent Member of the Supervisory Board | Profile | |
| Monique Eeuwijk | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Jacobus Schouten | Managing Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.316 | Dividend Share 0.04 | Earnings Share 0.54 | Revenue Per Share 11.158 | Quarterly Revenue Growth 0.072 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Core Laboratories' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.